Analysis of data collected from clinic reproduced psoriasis drug trial results

The difference in effect of two drugs commonly used to treat psoriasis was reliably reproduced from a clinical trial by a large observational study carried out by University of Manchester and Salford Royal NHS Foundation Trust scientists. The study from the British Association of Dermatologists Biologics and Immunomodulator Register (BADBIR) compared the effectiveness of secukinumab against ustekinumab, two biologics used to treat the common chronic inflammatory skin condition psoriasis.